Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
secondary source
Title:
Unnamed
Year:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
Buehler test
Justification for non-LLNA method:
The skin sensitisation in-vivo (non-LLNA) experimental study reported in this section should be considered as acceptable since it was performed before the LLNA skin sensitisation method was considered to be the preferred one for new in-vivo testings.

Moreover and according to ECHA guidance R.7a, page 234, existing data of good quality derived from tests such as the Buehler test are acceptable and, if they provide clear results, will preclude the need for further in vivo testing.

Test material

Constituent 1
Chemical structure
Reference substance name:
4,4'-oxydiphthalic anhydride
EC Number:
412-830-4
EC Name:
4,4'-oxydiphthalic anhydride
Cas Number:
1823-59-2
Molecular formula:
C16H6O7
IUPAC Name:
5-[(1,3-dioxo-1,3-dihydro-2-benzofuran-5-yl)oxy]-1,3-dihydro-2-benzofuran-1,3-dione
Test material form:
solid: particulate/powder

In vivo test system

Test animals

Species:
guinea pig
Strain:
not specified
Sex:
not specified

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100%
Adequacy of induction:
other: Information on adequacy of induction not available
Challenge
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
100%
Adequacy of challenge:
other: Information on adequacy of challenge not available
No. of animals per dose:
Number of animals in test group: 10
Number of animals in negative control group: 10
Positive control substance(s):
not specified

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
100%
No. with + reactions:
0
Total no. in group:
10

Any other information on results incl. tables

Maximum concentration not causing irritating effects in preliminary test: 50%

Signs of irritation during induction:

Signs of irritation during induction were not scored during this test.

Evidence of sensitisation of each challenge concentration: None

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Not classified.